Factors associated with lipid lowering therapy in the multi-ethnic study of atherosclerosis
Abstract Background Lipid-lowering therapy (LLT) plays a central role in managing atherosclerotic cardiovascular disease (ASCVD) risk, but its underuse is reported in over 40% of the qualified population in the United States. Studies on factors, particularly actionable factors associated with guidel...
Saved in:
| Main Authors: | Jing Cao, Weihua Guan, Sarah O. Nomura, Harpreet S. Bhatia, Parveen K. Garg, Michael Y. Tsai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Series: | Lipids in Health and Disease |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12944-024-02363-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Triglyceride-rich lipoproteins cholesterol, 10-years atherosclerotic cardiovascular disease risk, and risk of myocardial infarction and ischemic stroke
by: Yi-Ping Jia, et al.
Published: (2024-11-01) -
Achievement of guideline-based lipid goals among very-high-risk patients with atherosclerotic cardiovascular disease and type 2 diabetes: results in 213,380 individuals from the cvMOBIUS2 registry
by: Satoshi Shoji, et al.
Published: (2025-03-01) -
Lipoprotein(a), high-sensitivity c-reactive protein, homocysteine and cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis
by: Sarah O. Nomura, et al.
Published: (2025-03-01) -
“Inclisiran: Early LDL-C target achievement in a real-life population”
by: Francesco Briani, et al.
Published: (2025-03-01) -
Real-World Application of Evolocumab Among Patients with Hyperlipidemia in Korea: A Multicenter Prospective Study
by: Min Chul Kim, et al.
Published: (2024-10-01)